Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2020)
Rezolute (RZLT) posted Other Non-Current Liabilities of $12000.0 for Q1 2020, down 75.0% sequentially from $48000.0 in Q4 2019, and down 57.89% YoY from $28499.0 in Q2 2019.
Powered by 
Analysis
Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2020) Analysis & Trends
Rezolute has reported Other Non-Current Liabilities for 7 years, with the latest figure at $12000.0 in Q1 2020.
- Quarterly Other Non-Current Liabilities fell 57.89% year-over-year to $12000.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $12000.0 (down 57.89% YoY) and the FY2019 annual result came in at $121000.0, down 43.98% from the prior year.
- Other Non-Current Liabilities retreated to $12000.0 in Q1 2020 per RZLT's latest filing, from $48000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $431341.0 in Q1 2016 and troughed at $12000.0 in Q1 2020.
- A 5-year average of $221431.7 and a median of $229843.0 in 2017 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2016 and 2019: Other Non-Current Liabilities surged 149.61% in 2016, then slumped 86.58% in 2019.
- Over 5 years, Other Non-Current Liabilities stood at $335588.0 in 2016, then slipped by 27.39% to $243686.0 in 2017, then tumbled by 39.17% to $148224.0 in 2018, then tumbled by 67.62% to $48000.0 in 2019, then slumped by 75.0% to $12000.0 in 2020.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $12000.0, $48000.0, and $85000.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 12,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Sep 30, 2019 | 85,000.00 |
| Jun 30, 2019 | 121,000.00 |
| Mar 31, 2019 | 28,499.00 |
| Sep 30, 2018 | 148,224.00 |
| Jun 30, 2018 | 216,000.00 |
| Mar 31, 2018 | 212,358.00 |
| Dec 31, 2017 | 243,686.00 |
| Sep 30, 2017 | 274,130.00 |
| Jun 30, 2017 | 304,575.00 |
| Mar 31, 2017 | 314,655.00 |
| Dec 31, 2016 | 335,588.00 |
| Sep 30, 2016 | 367,813.00 |
| Jun 30, 2016 | 400,038.00 |
| Mar 31, 2016 | 431,341.00 |
| Dec 31, 2015 | 460,794.00 |
| Sep 30, 2015 | 453,586.00 |
| Jun 30, 2015 | 480,490.00 |
| Mar 31, 2015 | 506,499.00 |